Skip to main content
Premium Trial:

Request an Annual Quote

Fasteris Becomes First European Certified Service Provider for Agilent's Target-Enrichment System

Premium

Agilent Technologies said this week that sequencing service provider Fasteris has become the first European certified -service provider for Agilent's SureSelect Target Enrichment System.

SureSelect, an in-solution target enrichment method, was introduced in February and allows sequencing experiments to focus on specific genomic regions, rather than the entire genome.

Geneva, Switzerland-based Fasteris reached CSP status after it demonstrated "a high level of proficiency" using the SureSelect system with the Illumina Genome Analyzer.

"We have been impressed by the SureSelect technology with its high proportion of reads on target and resulting reduction in downstream sequencing costs on the Illumina Genome Analyzer," Fasteris founder and CEO Laurent Farinelli said in a statement.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.